| Literature DB >> 35451602 |
Rossella Marcucci1,2, Lucia Mannini1, Valentina Andrei3, Brunella Bandinelli1, Anna Maria Gori1,2, Serena Fatucchi3, Cristina Giglioli3, Salvatore Mario Romano2,3, Chiara Piazzai3, Niccolo' Marchionni3, Emanuele Cecchi4.
Abstract
Takotsubo syndrome (TTS) is an acute and usually reversible heart failure syndrome, frequently associated with emotional or physical stress. Its pathophysiology remains largely unclear, although several mechanisms related to catecholaminergic storm have been proposed. In this study we analyzed during the acute phase of TTS and at follow-up both hemorheological parameters and biomarkers of endothelial damage, whose time course has never been fully explored. In 50 TTS women, we analyzed several hemorheological parameters [whole blood viscosity (WBV) at 0.512 s-1 and at 94.5 s-1, plasma viscosity (PLV), erythrocyte deformability and aggregation index] as well as biomarkers of endothelial dysfunction [von Willebrand Factor (vWF), Plasminogen activator inhibitor-1 and factor VIII levels] during the acute phase and after a median 6 months follow-up. These variables were also assessed in 50 age-matched healthy women. Respect to follow-up, in the acute phase of TTS we observed higher values of white blood cell count, fibrinogen, WBV at low and high shear rates, PLV, erythrocyte aggregation index and lower values of erythrocyte elongation index. Moreover, all biomarkers of endothelial dysfunction resulted significantly higher in the acute phase. During follow-up WBV at 94.5 s-1, erythrocyte elongation index and vWF resulted significantly altered with respect to controls. The results of this study confirm the role of hyperviscosity and endothelial dysfunction in TTS pathophysiology. Moreover, they suggest the persistence of alterations of erythrocyte deformability and endothelial dysfunction even beyond the acute phase that could be the target of therapeutic strategies also during follow-up.Entities:
Keywords: Endothelial dysfunction; Hemorheology; Hyperviscosity; Takotsubo syndrome
Mesh:
Substances:
Year: 2022 PMID: 35451602 DOI: 10.1007/s00380-022-02071-6
Source DB: PubMed Journal: Heart Vessels ISSN: 0910-8327 Impact factor: 1.814